Efavirenz, Emtricitabine And Tenofovir Disoproxil Fumarate Tablet, Film Coated
Product Images NDC 72162-2565

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Efavirenz, Emtricitabine And Tenofovir Disoproxil Fumarate (NDC 72162-2565). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Efavirenz Chemical Structure (Efemtf Str1)

FDA Label Image

Emitricitabine Chemical Structure (Efemtf Str2)

FDA Label Image

Tenofovir Chemical Structure (Efemtf Str3)

FDA Label Image

Label (Lbl721622565)

Label (Lbl721622565)
Each film-coated tablet contains 600 mg of Efavirenz USP, 200 mg of Emtricitabine, and 300 mg of Tenofovir Disoproxil Fumarate which is equivalent to 245 mg of Tenofovir Disoproxil. It is advised to scan the package insert QR code for dosage and administration details. The medicine should be stored at 20° to 25°C (68° to 77°F) and kept out of reach of children. Dispense only in the original container and keep it tightly closed. It is crucial to find out about medicines that should not be taken with Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate tablets. Each package contains 30 tablets and is manufactured by Aurobindo Pharma Limited, relabeled by Bryant Ranch Prepack, Inc.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.